Presentation day of the Complementary Health Plan at the Carlos III Health Institute

 

During this Conference, Valentín Ceña presented line of action 5 at the University of Castilla-La Mancha: “Pharmacological characterization of nanoparticles” in collaboration with the Singular Center for Research in Molecular Medicine and Chronic Diseases (USC) and CICbioGUNE focused on treatment of glioblastoma with nanoparticles.

 

Jornada de presentación del Plan Complementario en Salud en el Instituto de Salud Carlos III

Lecture at the Royal National Academy of Pharmacy.

Professor Valentín Ceña belonging to the University of Castilla-La Mancha – Faculty of Medicine-Pharmacology (AB), Neurodeath Associated Unit (UCLM-CSIC) gave, on March 20 at the Royal National Academy of Pharmacy (RANF), a conference entitled: “Nanoparticles

+ info